Sandbox g25: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi- (talk | contribs) mNo edit summary |
Gerald Chi- (talk | contribs) mNo edit summary |
||
| Line 1: | Line 1: | ||
{|class="infobox" style="position: fixed; top: 183px; right: 20px; margin: 0 0 0 0; border: 0; float: right; width: 19%; background: #2A2A2A; border-radius: 10px 10px 10px 10px; -webkit-user-select: none; font-family: Arial;" cellpadding="0" cellspacing="0"; | {|class="infobox" style="position: fixed; top: 183px; right: 20px; margin: 0 0 0 0; border: 0; float: right; width: 19%; background: #2A2A2A; border-radius: 10px 10px 10px 10px; -webkit-user-select: none; font-family: Arial;" cellpadding="0" cellspacing="0"; | ||
|- | |- | ||
! style="padding: 1.5px 3px; background: #3F3F3F; border-radius: 5px 5px 5px 5px; box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5); font-weight: bold; font-size: 14px;" | [[Infectious Disease Project Organ-Based Infections#WikiDoc Infectious Disease Project — Antimicrobial Agents|{{Fontcolor|# | ! style="padding: 1.5px 3px; background: #3F3F3F; border-radius: 5px 5px 5px 5px; box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5); font-weight: bold; font-size: 14px;" | [[Infectious Disease Project Organ-Based Infections#WikiDoc Infectious Disease Project — Antimicrobial Agents|{{Fontcolor|#FFA500|Antimicrobial Agents}}]] | ||
|- | |- | ||
| style="padding: 1.5px 5px; background: #696969; border-radius: 5px 5px 5px 5px; box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5); font-weight: bold; font-size: 10px;" | <div class="mw-customtoggle-x1" style="cursor: pointer;">{{Fontcolor|# | | style="padding: 1.5px 5px; background: #696969; border-radius: 5px 5px 5px 5px; box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5); font-weight: bold; font-size: 10px;" | <div class="mw-customtoggle-x1" style="cursor: pointer;">{{Fontcolor|#FFA500| ▸ Alphabetical List}}</div><div class="mw-collapsible mw-collapsed" id="mw-customcollapsible-x1" style="font-size: 10px;"> | ||
---- | ---- | ||
[[Infectious Disease Project Antimicrobial Agents#A ⇧ Return to Top ⇧ |{{Fontcolor|#FFFFFF|'''A'''}}]] ● | [[Infectious Disease Project Antimicrobial Agents#A ⇧ Return to Top ⇧ |{{Fontcolor|#FFFFFF|'''A'''}}]] ● | ||
| Line 28: | Line 28: | ||
</div> | </div> | ||
|- | |- | ||
| style="padding: 1.5px 5px; background: #696969; border-radius: 5px 5px 5px 5px; box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5); font-weight: bold; font-size: 10px;" | <div class="mw-customtoggle-x2" style="cursor: pointer;>{{Fontcolor|# | | style="padding: 1.5px 5px; background: #696969; border-radius: 5px 5px 5px 5px; box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5); font-weight: bold; font-size: 10px;" | <div class="mw-customtoggle-x2" style="cursor: pointer;>{{Fontcolor|#FFA500| ▸ Categorical List}}</div><div class="mw-collapsible mw-collapsed" id="mw-customcollapsible-x2"> | ||
---- | ---- | ||
[[Infectious Disease Project Antimicrobial Agents#Antibacterial Agents ⇧ Return to Top ⇧ |{{Fontcolor|#FFFFFF|'''Antibacterial Agents'''}}]] ● | [[Infectious Disease Project Antimicrobial Agents#Antibacterial Agents ⇧ Return to Top ⇧ |{{Fontcolor|#FFFFFF|'''Antibacterial Agents'''}}]] ● | ||
| Line 34: | Line 34: | ||
[[Infectious Disease Project Antimicrobial Agents#Antifungal Agents ⇧ Return to Top ⇧ |{{Fontcolor|#FFFFFF|'''Antifungal Agents'''}}]] ● | [[Infectious Disease Project Antimicrobial Agents#Antifungal Agents ⇧ Return to Top ⇧ |{{Fontcolor|#FFFFFF|'''Antifungal Agents'''}}]] ● | ||
[[Infectious Disease Project Antimicrobial Agents#Antiparasitic Agents ⇧ Return to Top ⇧ |{{Fontcolor|#FFFFFF|'''Antiparasitic Agents'''}}]] ● | [[Infectious Disease Project Antimicrobial Agents#Antiparasitic Agents ⇧ Return to Top ⇧ |{{Fontcolor|#FFFFFF|'''Antiparasitic Agents'''}}]] ● | ||
[[Infectious Disease Project Antimicrobial Agents#Antiviral Agents ⇧ Return to Top ⇧ |{{Fontcolor|#FFFFFF|'''Antiviral Agents'''}}]] ● | [[Infectious Disease Project Antimicrobial Agents#Antiviral Agents ⇧ Return to Top ⇧ |{{Fontcolor|#FFFFFF|'''Antiviral Agents'''}}]] ● | ||
[[Infectious Disease Project Antimicrobial Agents#Antiretroviral Agents ⇧ Return to Top ⇧ |{{Fontcolor|#FFFFFF|'''Antiretroviral Agents'''}}]] | [[Infectious Disease Project Antimicrobial Agents#Antiretroviral Agents ⇧ Return to Top ⇧ |{{Fontcolor|#FFFFFF|'''Antiretroviral Agents'''}}]] | ||
| Line 66: | Line 65: | ||
</div> | </div> | ||
|- | |- | ||
| style="padding: 1.5px 5px; background: #696969; border-radius: 5px 5px 5px 5px; box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5); font-weight: bold; font-size: 10px;" | <div class="mw-customtoggle-x3" style="cursor: pointer;>{{Fontcolor|# | | style="padding: 1.5px 5px; background: #696969; border-radius: 5px 5px 5px 5px; box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5); font-weight: bold; font-size: 10px;" | <div class="mw-customtoggle-x3" style="cursor: pointer;>{{Fontcolor|#FFA500| ▸ Generic & Pharmaceutical Names}}</div><div class="mw-collapsible mw-collapsed" id="mw-customcollapsible-x3"> | ||
---- | ---- | ||
[[Infectious Disease Project Antimicrobial Agents#Generic Name ➡︎ Pharmaceutical Name ⇧ Return to Top ⇧ |{{Fontcolor|#FFFFFF|'''Generic Name ➡︎ Pharmaceutical Name'''}}]]<BR> | [[Infectious Disease Project Antimicrobial Agents#Generic Name ➡︎ Pharmaceutical Name ⇧ Return to Top ⇧ |{{Fontcolor|#FFFFFF|'''Generic Name ➡︎ Pharmaceutical Name'''}}]]<BR> | ||
| Line 72: | Line 71: | ||
</div> | </div> | ||
|- | |- | ||
| style="padding: 1.5px 5px; background: #696969; border-radius: 5px 5px 5px 5px; box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5); font-weight: bold; font-size: 10px;" | <div class="mw-customtoggle-x4" style="cursor: pointer;>{{Fontcolor|# | | style="padding: 1.5px 5px; background: #696969; border-radius: 5px 5px 5px 5px; box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5); font-weight: bold; font-size: 10px;" | <div class="mw-customtoggle-x4" style="cursor: pointer;>{{Fontcolor|#FFA500| ▸ Pregnancy Risk Categories}}</div><div class="mw-collapsible mw-collapsed" id="mw-customcollapsible-x4"> | ||
---- | ---- | ||
[[Infectious Disease Project Antimicrobial Agents#Risk Categories of Antibacterial Agents in Pregnancy ⇧ Return to Top ⇧ |{{Fontcolor|#FFFFFF|'''Antibacterial'''}}]] ● | [[Infectious Disease Project Antimicrobial Agents#Risk Categories of Antibacterial Agents in Pregnancy ⇧ Return to Top ⇧ |{{Fontcolor|#FFFFFF|'''Antibacterial'''}}]] ● | ||
| Line 82: | Line 81: | ||
</div> | </div> | ||
|- | |- | ||
| style="padding: 1.5px 5px; background: #696969; border-radius: 5px 5px 5px 5px; box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5); font-weight: bold; font-size: 10px;" | <div class="mw-customtoggle-x5" style="cursor: pointer;>{{Fontcolor|# | | style="padding: 1.5px 5px; background: #696969; border-radius: 5px 5px 5px 5px; box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5); font-weight: bold; font-size: 10px;" | <div class="mw-customtoggle-x5" style="cursor: pointer;>{{Fontcolor|#FFA500| ▸ Risk for TdP & QTc Prolongation}}</div><div class="mw-collapsible mw-collapsed" id="mw-customcollapsible-x5"> | ||
---- | ---- | ||
[[Infectious Disease Project Antimicrobial Agents#Risk categories for antimicrobial agents known to have an association with TdP ⇧ Return to Top ⇧ |{{Fontcolor|#FFFFFF|'''TdP Risk Categories'''}}]] ● | [[Infectious Disease Project Antimicrobial Agents#Risk categories for antimicrobial agents known to have an association with TdP ⇧ Return to Top ⇧ |{{Fontcolor|#FFFFFF|'''TdP Risk Categories'''}}]] ● | ||
| Line 88: | Line 87: | ||
</div> | </div> | ||
|- | |- | ||
| style="padding: 1.5px 5px; background: #696969; border-radius: 5px 5px 5px 5px; box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5); font-weight: bold; font-size: 10px;" | <div class="mw-customtoggle-x6" style="cursor: pointer;>{{Fontcolor|# | | style="padding: 1.5px 5px; background: #696969; border-radius: 5px 5px 5px 5px; box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5); font-weight: bold; font-size: 10px;" | <div class="mw-customtoggle-x6" style="cursor: pointer;>{{Fontcolor|#FFA500| ▸ Interactions with CYP Isoenzymes}}</div><div class="mw-collapsible mw-collapsed" id="mw-customcollapsible-x6"> | ||
---- | ---- | ||
[[Infectious Disease Project Antimicrobial Agents#Substrates of Cytochrome P-450 Isozymes|{{Fontcolor|#FFFFFF|'''CYP Substrates'''}}]] ● | [[Infectious Disease Project Antimicrobial Agents#Substrates of Cytochrome P-450 Isozymes|{{Fontcolor|#FFFFFF|'''CYP Substrates'''}}]] ● | ||
Revision as of 08:16, 7 June 2015
| Antimicrobial Agents |
|---|
▸ Alphabetical List
|
▸ Categorical List Antibacterial Agents ● Antimycobacterial Agents ● Antifungal Agents ● Antiparasitic Agents ● Antiviral Agents ● Antiretroviral Agents Natural Penicillins ● Antistaphylococcal Penicillins ● Aminopenicillins ● Antipseudomonal Penicillins ● Carbapenems ● Monobactam ● Fluoroquinolones ● Cephalosporins – 1st Generation ● Cephalosporins – 2nd Generation ● Cephalosporins – 3rd and 4th Generation ● Aminoglycosides ● Lincosamides ● Macrolides ● Ketolide ● Tetracyclines ● Glycylcycline ● Glycopeptides ● Urinary Tract Agents ● Topical Antibacterials ● Polymyxins and Colistin ● Rifamycin ● Antifolates ● Fusidanes ● Oxazolidinones ● Nitroimidazoles ● Streptogramins |
▸ Generic & Pharmaceutical Names
|
▸ Pregnancy Risk Categories
|
▸ Risk for TdP & QTc Prolongation
|
▸ Interactions with CYP Isoenzymes
|